News Standard BioTools Inc.

Equities

LAB

US34385P1084

Real-time Estimate Cboe BZX Other stock markets 11:48:48 2024-04-25 am EDT			5-day change	1st Jan Change
2.345 ^USD	-3.10%		-8.07%	+5.66%

02:01pm	Standard BioTools Inc. Announces Operational Restructuring Plan	CI
Apr. 16	TD Cowen Starts Standard BioTools With Buy Rating, $3.50 Price Target	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024	08:01am	AQ
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth	08:01am	AQ
Standard BioTools Inc. Announces Operational Restructuring Plan	08:01am	CI
TD Cowen Starts Standard BioTools With Buy Rating, $3.50 Price Target	Apr. 16	MT
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging	Apr. 08	AQ
Standard BioTools Inc. Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the Boundaries of Tissue Imaging	Apr. 08	CI
Jefferies Initiates Coverage on Standard BioTools With Buy Rating, $3.25 Price Target	Apr. 04	MT
Sector Update: Health Care Stocks Lean Higher Pre-Bell Thursday	Apr. 04	MT
Standard BioTools Enters Into Multi-Year Medicine Research Engagement With Bristol-Myers Squibb	Apr. 04	MT
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research	Apr. 03	AQ
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock	Mar. 18	AQ
Transcript : Standard BioTools Inc., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
Standard BioTools: Q4 Earnings Snapshot	Feb. 28	AQ
Standard BioTools Inc. Provides Revenue Guidance for the Full Year 2024	Feb. 28	CI
Standard BioTools Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Standard BioTools Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q4 Revenue $28.2M, vs. Street Est of $24.9M	Feb. 28	MT
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results	Feb. 28	AQ
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing	Feb. 26	AQ
Standard BioTools Inc. and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing	Feb. 26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Standard BioTools Inc.

Equities

LAB

US34385P1084

Summary

Filters